Scientific connotation of “treating different diseases with the same method” from the perspective of metabolic-immune dysregulation in inflammation-mediated carcinogenesis of digestive organs

Inflammation-mediated carcinogenesis develops in the context of chronic inflammation and is a significant cause of cancer within the digestive system.In the chronic inflammation microenvironment,the metabolic activity of tissue cells undergoes extensive changes,which interfere with the normal function of immune cells.Dysregulation of cell metabolism and immune function has been identified as a key factor contributing to inflammation-mediated carcinogenesis within the major digestive organs,such as the stomach,liver,and colorectum.This metabolic-immune imbalance also corresponds to traditional Chinese medicine(TCM)theories of“yin-yang disharmony”and“disharmony between Ying-nutrients and Wei-defense.”The metabolic-immune imbalance has also been regarded as the key factor supporting“treatment of different diseases with the same method”,in which the same approach is adopted in the treatment of different conditions.In the TCM treatment process,it is necessary to first identify TCM patterns and then apply the corresponding TCM to correct the dysregulated metabolic and immune function,thereby blocking the progression from inflammation to malignancy.Our study findings deepen the TCM understanding of metabolic-immune dysregulation and the relationship between metabolic-immune dysregulation,pattern identification,and treatment method.They also provide new insights for the treatment of inflammation-mediated carcinogenesis in major digestive organs and help us further explore the scientific connotation of the TCM strategy of“treating different diseases with the same method”.

Treat to target in Crohn’s disease:A practical guide for clinicians

A treat-to-target(T2T)approach applies the principles of early intervention and tight disease control to optimise long-term outcomes in Crohn's disease.The Selecting Therapeutic Targets in Inflammatory Bowel Disease(STRIDE)-II guidelines specify short,intermediate,and long-term treatment goals,documenting specific treatment targets to be achieved at each of these timepoints.Scheduled appraisal of Crohn’s disease activity against pre-defined treatment targets at these timepoints remains central to determining whether current therapy should be continued or modified.Consensus treatment targets in Crohn’s disease comprise combination clinical and patient-reported outcome remission,in conjunction with biomarker normalisation and endoscopic healing.Although the STRIDE-II guidelines endorse the pursuit of endoscopic healing,clinicians must consider that this may not always be appropriate,acceptable,or achievable in all patients.This underscores the need to engage patients at the outset in an effort to personalise care and individualise treatment targets.The use of non-invasive biomarkers such as faecal calprotectin in conjunction with cross-sectional imaging techniques,particularly intestinal ultrasound,holds great promise;as do emerging treatment targets such as transmural healing.Two randomised clinical trials,namely,CALM and STARDUST,have evaluated the efficacy of a T2T approach in achieving endoscopic endpoints in patients with Crohn’s disease.Findings from these studies reflect that patient subgroups and Crohn’s disease characteristics likely to benefit most from a T2T approach,remain to be clarified.Moreover,outside of clinical trials,data pertaining to the real-world effectiveness of a T2T approach remains scare,highlighting the need for pragmatic real-world studies.Despite the obvious promise of a T2T approach,a lack of guidance to support its integration into real-world clinical practice has the potential to limit its uptake.This highlights the need to describe strategies,processes,and models of care capable of supporting the integration and execution of a T2T approach in real-world clinical practice.Hence,this review seeks to examine the current and emerging literature to provide clinicians with practical guidance on how to incorporate the principles of T2T into routine clinical practice for the management of Crohn’s disease.

Three Cases of Treating Diseases with Tiaozhong Yiqi Decoction

This paper introduced three cases of treating diseases with Tiaozhong Yiqi Decoction.Tiaozhong Yiqi Decoction,first proposed in Treatise on the Spleen and Stomach written by Li Gao,is an effective prescription for treating the syndrome of dampness stagnancy due to spleen deficiency.The authors sorted out the treatment of some difficult and complicated diseases with this prescription and the curative effect is remarkable.Tiaozhong Yiqi Decoction is evolved from Buzhong Yiqi Decoction by removing ATRACTYLODIS MACROCEPHALAE RHIZOMA and ANGELICAE SINENSIS RADIX,and adding ATRACTYLODIS RHIZOMA and AUCKLANDIAE RADIX.It uses ASTRAGALI RADIX,GINSENG RADIX ET RHIZOMA,and GLYCYRRHIZAE RADIX ET RHIZOMA to benefit qi and invigorate spleen,so as to treat the deficiency of spleen;it uses BUPLEURI RADIX and CIMICIFUGAE RHIZOMA to raise the clear yang;it also uses ATRACTYLODIS RHIZOMA,CITRI RETICULATAE PERICARPIUM,and AUCKLANDIAE RADIX to harmonize the middle to dispel the dampness.In this paper,the case of tinnitus and deafness belongs to the syndrome of dampness stagnancy due to spleen deficiency,dampness obstruction due to qi block,and dampness accumulation affecting clear orifices.The case of red vaginal discharge belongs to the syndrome of sunken spleen qi due to spleen deficiency and sunken yin fire.The case of cough belongs to the spleen deficiency combined with earth not engendering metal.All cases were treated with Tiaozhong Yiqi Decoction,fully proving the mechanism of the same treatment for different diseases.Only by identifying disease causes and syndromes,may it be able to obtain remarkable curative effect.

Text Mining of Rheumatoid Arthritis and Diabetes Mellitus to Understand the Mechanisms of Chinese Medicine in Different Diseases with Same Treatment

Objective： To identify the commonalities between rheumatoid arthritis （RA） and diabetes mellitus （DM） to understand the mechanisms of Chinese medicine （CM） in different diseases with the same treatment. Methods： A text mining approach was adopted to analyze the commonalities between RA and DM according to CM and biological elements. The major commonalities were subsequently verified in RA and DM rat models, in which herbal formula for the treatment of both RA and DM identified via text mining was used as the intervention. Results： Similarities were identified between RA and DM regarding the CM approach used for diagnosis and treatment, as well as the networks of biological activities affected by each disease, including the involvement of adhesion molecules, oxidative stress, cytokines, T-lymphocytes, apoptosis, and inflammation. The Ramulus Cinnamomi-Radix Paeoniae Alba-Rhizoma Anemarrhenae is an herbal combination used to treat RA and DM. This formula demonstrated similar effects on oxidative stress and inflammation in rats with collagen-induced arthritis, which supports the text mining results regarding the commonalities between RA and DM. Conclusion： Commonalities between the biological activities involved in RA and DM were identified through text mining, and both RA and DM might be responsive to the same intervention at a specific stage.

Network pharmacology unveils spleen-fortifying effect of Codonopsis Radix on different gastric diseases based on theory of “same treatment for different diseases” in traditional Chinese medicine

Objective: "Same treatment for different diseases" is a unique treatment strategy under the guidance of traditional Chinese medicine(TCM) theory.Codonopsis Radix(Codonopsis pilosula,Dangshen in Chinese)with spleen-fortifying effect was employed to understand the strategy of "Same treatment for different diseases",based on its common mechanism in the treatment of gastric diseases including gastric ulcer,gastritis and gastric cancer via network pharmacology research.Methods:Network pharmacology research methods were used to analyze the interaction network and potential mechanisms of Dangshen in treating gastric ulcer,gastritis and gastric cancer.The active components and their target proteins of Dangshen were integrated from TCMSP,BATMAN-TCM databases.The targets of gastric ulcer,gastritis and gastric cancer were collected through GeneCards,PubMed,TDD and DisGeNET Database.Through screening,the key components and the key targets of Dangshen in treating gastric ulcer,gastritis and gastric cancer were obtained.After KEGG pathway analysis and GO analysis,the important pathways and biological processes were analyzed.Results:Through data and literature mining,the common and specific pharmaceutical effects and mechanism of Dangshen were summarized in these three gastric lesions.It was shown that Dangshen mainly acted on gastric ulcer,gastritis and gastric cancer through the overall regulation of the PI3K-AkT signaling pathway.With the development of the disease,it will gradually increase the control of inflammation through TNF,NF-κB and other inflammation-related signaling pathways to reduce inflammatory damage.For tumorigenesis,it pays more attention to inhibiting the ErbB signaling pathways to reduce the proliferation and migration of tumor cells.In addition,Dangshen's regulation of HIF-1 signaling pathway may also be beneficial for the treatment of gastric ulcer,gastritis and gastric cancer.Conclusion:Dangshen achieves spleen-fortifying effect on gastric diseases including gastric ulcer,gastritis and gastric cancer through multiple targets in multiple pathways,especially PI3K-AKT pathway and HIF-1 pathway.It could provide a scientific basis for understanding the strategy of "Same treatment for different diseases" in traditional Chinese medicine.

Mechanisms of Dihuang(Rehmanniae Radix)in treating diabetic nephropathy complicated with depression based on network pharmacology

Objective To predict the molecular mechanism of Dihuang(Rehmanniae Radix)in the treatment of diabetic nephropathy(DN)complicated with depression based on network pharmacology.Methods The components of Dihuang(Rehmanniae Radix)were identified from the Integrated Pharmacology-based Research Platform of Traditional Chinese Medicine(TCMIP),Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform(TCMSP),and relevant literature.The component targets were detected by combining the SwissTargetPrediction and Pub Chem databases.Disease targets were collected from the Therapeutic Target Database(TTD),Dis Ge NET,and Ensembl databases with“diabetic nephropathy”and“depression”as keywords.The disease-component targets were mapped using Venny 2.1.0 to obtain potential targets.A protein-protein interaction(PPI)network was constructed using the Search Tool for the Retrieval of Interacting Genes/Proteins(STRING)database and Cytoscape 3.7.2.The co-expression genes of the key targets were collected based on the COXPRESdb 7.3.Gene Ontology(GO)and Kyoto Encyclopedia of Genes and Genomes(KEGG)enrichment analysis were performed for potential targets using R language.Target-component docking was verified and evaluated using Discovery Studio 4.5.Results According to the databases and literature reports,Dihuang(Rehmanniae Radix)contained 65 active components,and had 155 related targets for the treatment of DN complicated with depression.PPI screening showed that the key targets included serine/threonine protein kinase 1(AKT1),signal transducer and activator transcription 3(STAT3),interleukin 6(IL-6),mitogen-activated protein kinase 1(MAPK1),and vascular endothelial growth factor A(VEGFA),etc.GO enrichment analysis mainly involved biological processes,such as lipid metabolism,protein secretion regulation,cell homeostasis,and phosphatidylinositol 3 kinase activity.KEGG pathway enrichment analysis included the role of the AGE-RAGE signaling pathway in diabetic complements,insulin resistance(IR),neurotrophin signal path,Toll-like receptor signaling pathway,relaxin signaling pathway,epidermal growth factor receptor tyrosine kinase inhibitors(EGFR-TKIs),etc.Molecular docking showed that the target had high affinity for stachyose,manninotriose,verbascose,nigerose,etc.Conclusion Based on network parmacology,this study preliminarily predict the effects of Dihuang(Rehmanniae Radix)in treating DN complicated with depression by regulating inflammation,glucose metabolism,nution nerve,etc.

Mechanisms of Huanglian Jiedu Decoction in treating coronary heart disease and type 2 diabetes mellitus based on network pharmacology

Objective:To explore the common mechanism of Huanglian Jiedu Decoction in treating coronary heart disease and type 2 diabetes by network pharmacology.Methods:All chemical components and targets of the four drugs in Huanglian Jiedu Decoction were retrieved through TCMSP,and the genes were standardized through Uniprot database.Acquire disease targets related to coronary heart disease and diabetes in OMIM and GeneCards databases.The network diagram of"drug-component-target-disease"is constructed by using the software of cytopscape 3.7.2,the PPI network diagram of protein interaction is constructed by using STRING database,and the network diagram of"drug-disease"core target is constructed by using the software of cytopscape 3.7.2.DAVID's online database platform was used to analyze GO biological process and KEGG pathway enrichment of common targets of Huanglian Jiedu Decoction in treating coronary heart disease and type 2 diabetes.Results:103 active ingredients of Huanglian Jiedu Decoction were retrieved,including 140 acting targets,5342 coronary heart disease targets,114 diabetes targets,and 14 common intersection targets of drugs and diseases,involving AR,PPARG,TNF,IL6,CCL2,VEGFA,PON1,etc.The GO biological process analysis results in 98 biological processes,10 cell components and 10 molecular functions.Among them are positive regulation of gene expression,positive regulation of nitric oxide biosynthesis process,Extracellular space,cytokine activity,steroid hormone receptor activity and other biological processes;The enrichment analysis of KEGG pathway yielded 20 signal pathways(P≤0.05).It mainly involves Malaria,cancer in cancer,HIF-1 signaling pathway,TNF signaling pathway,NOD-like receptor signaling pathway,PI3K-Akt signaling pathway,etc.Conclusion:Huanglian Jiedu Decoction"treats different diseases at the same time"coronary heart disease and type 2 diabetes have the characteristics of multiple components,multiple targets and multiple pathways,which provide theoretical basis for Huanglian Jiedu Decoction to treat coronary heart disease and type 2 diabetes in clinic,but the key targets and pathways of Huanglian Jiedu Decoction to treat diseases still need further experimental verification.

基于“肝脾同调”阐析慢性肝病的中医治疗

慢性肝病是临床常见疾病,“郁、虚、湿、毒、瘀”是其核心病机,在疾病的不同阶段各有侧重,其中,以“郁、虚”为核心的肝脾失调是慢性肝病发生发展的关键。“肝脾同调”是治疗慢性肝病的基本治法,在慢性肝病不同阶段,其“肝脾同调”内涵同中有异。根据肝、脾生理病理特性,治脾明辨虚实,厘清轻重,活用运脾、健脾、温脾、醒脾、补脾等法;调肝体用并重,精准辨证,活用疏肝、缓肝、散肝、柔肝等法。临床上,治脾与调肝相辅相成,治调并举,常获良效。

部分嵌套式设计在中医药“同病异治”疗效评价中的应用及方法学探索

目的本研究针对中医学同病异治、辨证论治的特征,引入部分嵌套式设计。方法部分嵌套式设计以复杂干预对照标准化治疗,中医组按“证型-治法-方药”分割为多个子集(存在嵌套结构),对照组采用标准化西医治疗(无嵌套结构);并以一项溃疡性结肠炎“同病异治”数据为例,套用该设计类型并采用多水平模型分析。结果部分嵌套式设计符合“同病异治”诊疗特征并满足循证评价的设计要求,通过多水平模型可实现类似数据结构的分析。结论利用部分嵌套式设计能实现对“同病异治”整体效果的评价,可为中医药临床疗效评价提供方法学参考。

桂枝茯苓丸化裁异病同治血瘀型功能性肛门直肠痛经验

目的总结运用桂枝茯苓丸化裁治疗血瘀型功能性肛门直肠痛的诊疗思路。方法通过研究古籍、搜集整理文献、整理验方,结合现代医家研究,从病因病机、用药特点等方面,分析总结运用桂枝茯苓丸化裁治疗血瘀型功能性肛门直肠痛的诊疗思路,并列举验案加以佐证。结果功能性肛门直肠痛始于气机升降功能的紊乱,血瘀是该病最终趋势,活血化瘀是中医辨治功能性肛门直肠痛的核心方法。结论桂枝茯苓丸在临床中多用于治疗妇科相关疾病,以异病同治创新性地将其引入血瘀型功能性肛门直肠痛的治疗中,临证经验提示疗效显著,为功能性肛门直肠痛的临床诊治提供了新的思路。

乳腺癌“应激治乳”新理论的构建与临床应用探讨

应激是生物体对内、外源性刺激的一种非特异的适应性反应,有助于维持机体内环境稳态。然而当应激反应的程度超过机体适应阈值,即可诱发多种疾病。乳腺癌发病率和死亡率高居女性恶性肿瘤前列,乳腺病领域首位国医大师林毅教授创立“六郁治乳”理论,认为六郁是乳腺癌发生发展的核心病机,而六郁与机体应激反应系统密切相关,中医药在调整应激稳态平衡领域有特色优势。该文基于中医经典理论、“六郁治乳”理论及现代应激理论,提出“应激治乳”学说,阐释应激因素介导乳腺癌发生发展的病机特性、致病特点、分子机制,提出基于应激稳态调控的核心思想和辨治原则,总结“应激治乳”理论指导下的遣方用药。“应激治乳”理论的构建丰富了中医乳腺癌理论体系,有望为改善乳腺癌患者的临床预后提供新路径。

基于网络药理学与分子对接技术探讨半夏厚朴汤“异病同治”胃食管反流病和慢性咽炎的作用机制

目的 基于中医学“异病同治”理论,运用网络药理学与分子对接技术探究半夏厚朴汤治疗胃食管反流病(GERD)和慢性咽炎的作用机制。方法 通过中药系统药理学数据库与分析平台、本草组鉴数据库、中医药百科全书数据库检索半夏厚朴汤活性成分及潜在靶点;通过GeneCards、TTD和OMIM数据库获得GERD和慢性咽炎相关靶点;通过Venny平台筛选药物与两种疾病的共同靶点;通过Cytoscape 3.9.1软件构建“药物-活性成分-共同靶点-疾病”网络,以展示其交互作用关系;通过STRING平台构建共同靶点PPI网络;通过Metascape平台对共同靶点进行GO功能及KEGG通路富集分析;运用Schr9dinger Suite对关键靶点和所有活性成分进行分子对接,验证潜在作用靶点与药物成分的结合能力,并筛选出主要活性成分。结果 共筛选半夏厚朴汤活性成分46个,得到药物靶点223个,共获得GERD疾病靶点2 170个,慢性咽炎疾病靶点402个,筛选得到疾病与药物共有靶点59个;其中核心靶点涉及IL-6、TNF、AKT1、IL-1β、VEGFA等;GO分析显示,共有靶点主要参与细胞群增殖的负调控、细胞转运的正向调控、炎症应答等生物过程;KEGG富集结果显示,共有靶点与癌症通路、JAK-STAT、NF-κB等信号通路相关。分子对接结果显示,核心蛋白与大多数活性成分存在结合位点,其中槲皮素、(+)-儿茶素、刺槐苷B、黄芩苷、鞣花酸等成分与核心靶点结合较为稳定,可推测为“异病同治”主要成分。结论 半夏厚朴汤可通过多成分、多靶点、多通路抑制细胞凋亡、减少炎症反应以及调节免疫等发挥对GERD和慢性咽炎的“异病同治”作用。

从气血同治探讨慢性气道疾病的异病同治

支气管哮喘和慢性阻塞性肺疾病(简称慢阻肺)同属慢性气道炎症疾病,在病机和治法上有一定的相似性,其都可通过调节气血以恢复肺气宣肃,行使正常生理功能。针对肺的生理功能和气血的关系,探讨支气管哮喘和慢阻肺的共同病机:支气管哮喘的基本病机是痰伏于肺,外邪引动,痰气互结,肺失宣降,并可兼有瘀血阻络之象;慢阻肺的病机以久病肺虚为本,加之痰浊、水饮、瘀血等病理产物,使得肺失宣降,本虚标实的病机随病程持续进展;进而从气血同治角度探讨支气管哮喘和慢阻肺2种慢性气道疾病的异病同治,得出“气血同治,畅通气道”的治疗理念。结合成药的应用,分析以此病机为指导的丹龙口服液组方特点和功效主治,为丹龙口服液异病同治2种气道疾病提供理论依据。

基于网络药理学和分子对接技术探讨血府逐瘀汤“异病同治”治疗冠心病和缺血性脑卒中的作用机制

目的 通过网络药理学方法结合分子对接技术探讨血府逐瘀汤“异病同治”治疗冠心病和缺血性脑卒中的作用机制。方法 在TCMSP数据库检索并结合文献筛选血府逐瘀汤11味中药的活性成分和作用靶点,通过Uniprot数据库匹配靶点官方名称。从OMIM、DrugBank、DisGNET、TTD、GeneCards数据库获取冠心病和缺血性脑卒中相关疾病靶点,取交集靶点,构建“单味药—共有靶点—疾病”网络。建立蛋白间相互作用网络,利用Centiscape插件筛选关键靶点,利用MetaScape数据库进行GO功能分析和KEGG通路富集分析。通过AutoDockTools-1.5.6进行分子对接预测。结果 筛选后得到血府逐瘀汤活性成分192个,作用靶点394个;与冠心病和缺血性脑卒中相关且排序靠前的通路有脂质和动脉粥样硬化、缺氧诱导因子-1、松弛素、核因子-κB信号通路等,主要与脂质代谢、炎症反应、氧化应激、血管生成和细胞凋亡等生物学过程相关。本方中主要活性成分木犀草素、山柰酚、柚皮素与靶点蛋白蛋白激酶1、白蛋白、胰岛素结合较好。结论 基于网络药理学的方法发现血府逐瘀汤通过多靶点、多途径治疗冠心病和缺血性脑卒中,且多个成分表现出良好的活性;可能通过抗氧化、抗炎、抑制细胞凋亡、调节激素水平、促进血管生成等作用,改善局部缺血缺氧状态,发挥“异病同治”作用。

名中医李海松运用“五辨”模式治疗男性不育症临床经验

男性不育症是中医学的优势病种之一,中医药在改善男性生殖功能方面具有独特优势。然随着自然环境及人们生活习惯的改变,男性不育症的病因病机趋于复杂化及多样化,目前单一的辨证论治模式已无法满足临床的需求,因此亟需探索一种新的中医辨治模式。李海松教授经过长期的临床实践,以及结合现代医学相关研究,针对男性不育症形成了“五辨”的诊治模式,即辨病论治、辨证论治、辨精论治、辨体论治、无症可辨。以辨证论治为核心,辨病论治为前提,重视辨精论治,同时兼顾体质因素,而无症可辨者从肾虚血瘀论治,在以上多种辨治方法的协同下,能够有效提高男性不育症的整体临床疗效。

基于血水同治法刍议当归贝母苦参丸之异病同治

目的 基于血水同治法刍议当归贝母苦参丸之异病同治。方法 以血水同治法为理论依据,结合当归贝母苦参丸之组方原理,探讨其异病同治之临床应用。结果 当归贝母苦参丸为血水同治法代表方剂,为治疗妇女妊娠并发小便难之名方。现代中医学者基于其血水同治的组方思路,扩展其临床应用,如盆腔炎、前列腺炎、慢性便秘、溃疡性结肠炎,以及肿瘤类疾病。结论 当归贝母苦参丸之异病同治皆为其血水同治之配伍功效与多种疾病之病机吻合,临证之时应灵活加减。

李飞针灸治疗面瘫经验举隅

总结李飞教授治疗面瘫的学术思想及诊疗经验。李飞提出诊治面瘫时应遵循“初病审因,次探病机,再明病证,辨证论治”,以祛风通络、疏调筋经为基本治疗原则。临床治疗时,以“重视解剖,依症施治”为基本方针,贯通中西理论,结合表情肌解剖结构,动态化判断神经、肌肉恢复情况,依据症状选取相应经验组穴。重视整合理论,总结理法辨证、分期辨证、症状辨证之“辨证三重”法则,调经、调筋、调神之“治疗三调”理论,值得临床借鉴。

薛一涛运用膏方辨治心系疾病思路探析

膏方在治疗慢性疾病方面,具有平调、缓图、长效的特点,薛一涛教授使用膏方治疗心系疾病经验丰富,见解独到,临床上将“辨体-辨病-辨证”与“因时-因人-因地”相结合,灵活考究用药、化裁处方,并以“一脏为主,兼调五脏”为纲,应用膏方防治心系疾病的传变。根据患者的个人体质使用膏方进行调补,可增强体质,不仅能扶正祛邪,对于疾病的并发症也有很好的治疗及预防作用。

基于《治肝三十法》探析从肝论治间质性肺疾病咳嗽

清代医家王旭高以肝气、肝火、肝风、肝虚为纲,总结创立了《治肝三十法》。以《治肝三十法》为立足点探析肝气、肝火、肝风、肝虚的源流及内涵,并探讨间质性肺疾病的病机变化与其相似之处,从而提出从肝论治间质性肺疾病咳嗽,分析并探索间质性肺疾病相关咳嗽的临床用药规律及有效方剂,并应用典型案例验证其临床疗效,希望能对中医辨治间质性肺疾病相关咳嗽提供新的思路及方法。

基于网络药理学及分子对接技术探讨金匮肾气丸“异病同治”多囊卵巢综合征和甲状腺功能减退的作用机制

目的 以中医“异病同治”理论为依据,采用网络药理学与分子对接方法探究金匮肾气丸对多囊卵巢综合征和甲状腺功能减退的作用机制。方法 自2022年3—10月通过中药系统药理学数据库与分析平台(TCMSP)检索获取金匮肾气丸活性成分及潜在靶点,利用DrugBank、GeneCards数据库获取疾病靶点,将两者取交集获取共有靶点,通过STRING11.5数据库构建蛋白质-蛋白质相互作用(PPI)网络,使用Cytoscape 3.7.1构建金匮肾气丸“药物-疾病-靶点”网络,利用R语言对共有靶点进行富集分析,运用SYBYL-X 2.0软件进行分子对接。结果 筛选得到疾病与药物共有靶点65个,核心靶点主要涉及血管内皮生长因子A(VEGFA)、白细胞介素-6(IL-6)、肿瘤坏死因子α(TNF-α)、胱天蛋白酶-3(CASP-3)、细胞肿瘤抗原p53(TP53)、基质金属蛋白酶-9(MMP-9)等,潜在靶点主要富集在AGE-RAGE信号通路、癌症的途径、PI3K-Akt信号通路、胰岛素抵抗、JAK-STAT信号通路等多条信号通路中。结论 金匮肾气丸中多种活性成分通过多靶点、多途径发挥抑制炎症反应及细胞凋亡、促进组织血管生成等作用,初步揭示了金匮肾气丸“异病同治”多囊卵巢综合征与甲状腺功能减退的潜在靶点与现代生物学机制,为深入研究开展实验及临床应用提供参考。